Effect of colchicine on circulating and myocardial neutrophils and on infarct size in a canine model of ischemia and reperfusion

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 6, 1996, Pages 876-883

  Forrat, Rémi ^a   Sebbag, Laurent ^a   Ferrera, René ^a   Hadour, Guylaine ^a   Canet, Emmanuelle ^a   Tabib, Alain ^b   De Lorgeril, Michel ^a  

^a CNRS   (France)

^b LOUIS PRADEL HOSPITAL   (France)

Author keywords

Colchicine; Collateral flow; Myocardial infarction; Neutrophil; Reperfusion injury

Indexed keywords

COLCHICINE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; COLLATERAL CIRCULATION; CONTROLLED STUDY; DOG; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; LEUKOCYTE COUNT; LEUKOCYTOSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COLCHICINE; CORONARY CIRCULATION; DOGS; FEMALE; HEART; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHILS;

EID: 0029973069     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199606000-00016     Document Type: Article

References (35)

1. Go LO, Murry CE, Richard VJ, Weischedel GR, Jennings RB, Reimer KA. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury. Am J Physiol 1988;255:H1188-98.
2. Chatelain P, Latour JG, Tran D, de Lorgeril M, Dupras G, Bourassa M. Neutrophil accumulation in experimental myocardial infarct: relation with extent of injury and effect of reperfusion. Circulation 1987;75:1083-90.
3. de Lorgeril M, Rousseau G, Basmadjian A, Saint-Jean G, Tran DC, Latour JG. Spacial and temporal profiles of neutrophil accumulation in the reperfused ischemic myocardium. Am J Cardiovasc Pathol 1990;3:143-54.
4. Engler RL, Dahlgren MD, Peterson MA, Dobbs A, Schmid-Schonbein GW. Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am J Physiol 1986;251:H93-100.
5. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation 1989;80:1816-27.
6. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983;67:1016-23.
7. de Lorgeril M, Basmadjian A, Lavallee M, et al. Influence of leukopenia on collateral flow, reperfusion flow, reflow ventricular fibrillation, and infarct size in dogs. Am Heart J 1989;117:523-32.
8. Simpson PJ, Todd RF III, Mickelson JK, et al. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation 1990;81: 226-37.
9. Simpson PJ, Mitsos SE, Ventura A, et al. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J 1987;113:129-37.
10. Mullane KM, Read N, Salmon JA, Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther 1984;228:510-22.
11. Ma XL, Weyrich AS, Lefer DJ, et al. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation 1993; 88:649-58.
12. Weyrich AS, Ma XL, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:2620-9.
13. Tanaka M, Brooks SE, Richard VJ, et al. Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs. Circulation 1993;87:526-35.
14. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;6:365-76.
15. Malawista SE, Bench KG. Human polymorphonuclear leukocytes: demonstration of microtubules and effects of colchicine. Science 1967;156:521-2.
16. Dallaverde E, Fan PT, Chang Y. Mechanism of action of colchicine. Neutrophil adherence and phagocytosis in patients with acute gout treated with colchicine. J Pharmacol Exp Ther 1982;1:197-202.
17. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial Mediterranean fever: a double blind study. N Engl J Med 1974;291:934-6.
18. Wright DG, Ungerleider RD, Gallin JI, Deisseroth AB. Pretreatment of filtration leukapheresis donors with colchicine. Blood 1978;52:783-92.
19. Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994;26: 661-8.
20. Sato H, Hori M, Kitakaze M, et al. Reperfusion after brief ischemia disrupts the microtubule network in canine hearts. Circ Res 1993;72:361-75.
21. Reimer KA, Jennings RB, Cobb FR, et al. Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study. Comparison of unconscious and conscious dog models. Circ Res 1985;56:651-65.
22. Hoshida S, Kuzuya T, Fuji H, Oe H, Tada M. Transcardiac alteration of neutrophil function relates to myocardial ischemia/reperfusion injury. Cardiovasc Res 1993;27:377-83.
23. de Lorgeril M, Basmadjian A, Clement R, Rousseau G, Latour JG. Influence of reflow ventricular fibrillation and electrical defibrillation on infarct size in a canine preparation of myocardial infarction. Cardiovasc Res 1990;24:151-5.
24. Stapczinski JS, Rothstein RJ, Gaye WA, Niemann JT. Colchicine overdose: report of two cases and review of the literature. Ann Emerg Med 1981;10:364-9.
25. Mery P, Riou B, Chemla D, Lecarpentier Y. Cardiotoxicity of colchicine in the rat. Intensive Care Med 1994;20:119-23.
26. Van Winkle DM, Matsuki T, Gad NM, Jordan MC, Downey JM. Left ventricular unloading during reperfusion does not limit myocardial infarct size. Circulation 1990;81:1374-9.
27. Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O. Role of adenosine receptor activation in myocardial infarct size limitation by ischemic preconditioning. Cardiovasc Res 1992;226:456-61.
28. Tsuchida A, Liu GS, Wilborn WH, Downey JM. Pretreatment with the adenosine A1 selective agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits. Cardiovasc Res 1993;27:652-6.
29. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 1992;26:101-8.
30. Entman ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 1994;28:1301-11.
31. Lefer AM, Weyrich AS, Buerke M. Role of selectins, a new family of adhesion molecules, in ischemia-reperfusion injury. Cardiovasc Res 1994;28:289-94.
32. Diaz-Gonzalez F, Gonzalez-Alvaro I, Campanero MR, et al. Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. J Clin Invest 1995;95:1756-65.
33. Winquist RJ, Frei PP, Letts LG, Andrews L, Rothlein R, Mintze L. Monoclonal antibody to intercellular adhesion molecule-1 but not to endothelial-leukocyte adhesion molecule-1, protects against myocardial ischemia/reperfusion damage in anesthetized monkeys [Abstract]. Circulation 1992;86(suppl 1):79.
34. Chen LY, Nichols WW, Hendricks JB, Yang BC, Mehta JL. Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc Res 1994;28:1414-22.
35. Kubes P, Jutila M, Payne D. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 1995;95:2510-9.